Format

Send to

Choose Destination
Epilepsy Behav. 2019 Aug;97:282-290. doi: 10.1016/j.yebeh.2019.04.042. Epub 2019 Jul 6.

Novel therapies for epilepsy in the pipeline.

Author information

1
Hamad Medical Corporation and Weill Cornell Medical College-Qatar, Doha, Qatar. Electronic address: boulenouar.mesraoua@wanadoo.fr.
2
Hamad Medical Corporation and Weill Cornell Medical College-Qatar, Doha, Qatar. Electronic address: ddeleu@hamad.qa.
3
UCL Institute of Neurology, University College London, United Kingdom. Electronic address: d.kullmann@ucl.ac.uk.
4
Institute for Regenerative Medicine, Department of Molecular and Cellular Medicine, Texas A&M University College of Medicine, College Station, TX, USA. Electronic address: shetty@medicine.tamhsc.edu.
5
Reference Center for Refractory Epilepsy, Ghent University Hospital Belgium - Academic Center for Epileptology, Heeze-Maastricht, the Netherlands. Electronic address: paul.boon@ugent.be.
6
Unit of Clinical and Experimental Pharmacology, Department of Internal Medicine and Therapeutics, University of Pavia, and Clinical Trial Center, IRCCS Mondino Foundation, Pavia, Italy. Electronic address: perucca@unipv.it.
7
Division of Pediatric Neurology and Developmental Medicine, Duke University Medical Center, Durham, USA. Electronic address: mohamad.mikati@duke.edu.
8
Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran; Jefferson Comprehensive Epilepsy Center, Department of Neurology, Thomas Jefferson University, Philadelphia, USA. Electronic address: aliasadipooya@yahoo.com.

Abstract

Despite the availability of many antiepileptic drugs (AEDs) (old and newly developed) and, as recently suggested, their optimization in the treatment of patients with uncontrolled seizures, more than 30% of patients with epilepsy continue to experience seizures and have drug-resistant epilepsy; the management of these patients represents a real challenge for epileptologists and researchers. Resective surgery with the best rates of seizure control is not an option for all of them; therefore, research and discovery of new methods of treating resistant epilepsy are of extreme importance. In this article, we will discuss some innovative approaches, such as P-glycoprotein (P-gp) inhibitors, gene therapy, stem cell therapy, traditional and novel antiepileptic devices, precision medicine, as well as therapeutic advances in epileptic encephalopathy in children; these treatment modalities open up new horizons for the treatment of patients with drug-resistant epilepsy.

KEYWORDS:

Drug resistance; Epilepsy; Seizure; Treatment

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center